問卷

TPIDB > Search Result

Search Result

篩選

List

22Cases

2024-01-01 - 2025-12-31

Phase I

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Recruiting1Sites

2025-06-30 - 2027-12-31

Phase I

Active
  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Recruiting1Sites

2019-07-01 - 2020-06-30

Phase I

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Terminated1Sites

2022-01-15 - 2022-04-15

Phase I

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Terminated1Sites

2014-09-01 - 2018-11-30

Phase III

Completed
A Randomized Phase 3 Study of LY2835219 plus Best Supportive Care versus Erlotinib plus Best Supportive Care in Patients with Stage IV NSCLC with a Detectable KRAS Mutation Who Have Progressed After Platinum-Based Chemotherapy
  • Condition/Disease

    Non Small Cell Lung Cancer

  • Test Drug

    LY2835219

Participate Sites
11Sites

Terminated11Sites

2023-02-02 - 2023-03-09

Phase I

  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Recruiting1Sites

2021-12-15 - 2022-01-30

Others

  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Terminated1Sites

2021-05-10 - 2023-10-06

Phase I

  • Condition/Disease

  • Test Drug

Participate Sites
2Sites

Recruiting2Sites

2021-04-01 - 2021-07-30

Others

  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Terminated1Sites

2008-12-01 - 2009-06-30

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
19Sites

Terminated19Sites

1 2 3